The importance of scalability cannot be overstated. In the early phases of drug discovery, small-scale assays are sufficient. However, as a compound progresses through clinical trials, the need for larger-scale, high-throughput assays becomes imperative. Scalability ensures that the initial methods developed can be adapted for these larger scales without significant modifications, thereby saving time and resources.
